• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构导向的抗菌药物作用途径研究。

Structural approaches to pathway-specific antimicrobial agents.

机构信息

Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, Illinois.

Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois.

出版信息

Transl Res. 2020 Jun;220:114-121. doi: 10.1016/j.trsl.2020.02.001. Epub 2020 Feb 6.

DOI:10.1016/j.trsl.2020.02.001
PMID:32105648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293926/
Abstract

This perspective provides an overview of the evolution of antibiotic discovery from a largely phenotypic-based effort, through an intensive structure-based design focus, to a more holistic approach today. The current focus on antibiotic development incorporates assay and discovery conditions that replicate the host environment as much as feasible. They also incorporate several strategies, including target identification and validation within the whole cell environment, a variety of target deconvolution methods, and continued refinement of structure-based design approaches.

摘要

本文从一个主要基于表型的努力的角度,概述了抗生素发现的演变过程,通过密集的基于结构的设计重点,到今天的更全面的方法。目前对抗生素开发的重点包括尽可能复制宿主环境的测定和发现条件。它们还包括几种策略,包括在整个细胞环境中进行目标鉴定和验证、各种目标分解方法,以及继续改进基于结构的设计方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/d17017bec825/nihms-1575362-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/7c5732f2bac5/nihms-1575362-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/800dc9e4ba51/nihms-1575362-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/3328c4fcf3c5/nihms-1575362-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/d17017bec825/nihms-1575362-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/7c5732f2bac5/nihms-1575362-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/800dc9e4ba51/nihms-1575362-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/3328c4fcf3c5/nihms-1575362-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f301/7293926/d17017bec825/nihms-1575362-f0004.jpg

相似文献

1
Structural approaches to pathway-specific antimicrobial agents.结构导向的抗菌药物作用途径研究。
Transl Res. 2020 Jun;220:114-121. doi: 10.1016/j.trsl.2020.02.001. Epub 2020 Feb 6.
2
Structure-based approaches to antibiotic drug discovery.基于结构的抗生素药物发现方法。
Curr Protoc Microbiol. 2009 Feb;Chapter 17:Unit17.2. doi: 10.1002/9780471729259.mc1702s12.
3
Systems-level antimicrobial drug and drug synergy discovery.系统水平的抗菌药物和药物协同作用发现。
Nat Chem Biol. 2013 Apr;9(4):222-31. doi: 10.1038/nchembio.1205.
4
Crystallizing new approaches for antimicrobial drug discovery.为抗菌药物研发开辟新途径。
Biochem Pharmacol. 2006 Mar 30;71(7):1048-56. doi: 10.1016/j.bcp.2005.12.024. Epub 2006 Feb 3.
5
Strategies for discovery of new molecular targets for anti-infective drugs.抗感染药物新的分子靶标的发现策略。
Curr Opin Pharmacol. 2019 Oct;48:57-68. doi: 10.1016/j.coph.2019.04.015. Epub 2019 May 28.
6
Omics of antimicrobials and antimicrobial resistance.抗微生物药物组学与抗微生物药物耐药性。
Expert Opin Drug Discov. 2019 May;14(5):455-468. doi: 10.1080/17460441.2019.1588880. Epub 2019 Mar 19.
7
Using bacterial genomes and essential genes for the development of new antibiotics.利用细菌基因组和必需基因开发新型抗生素。
Biochem Pharmacol. 2017 Jun 15;134:74-86. doi: 10.1016/j.bcp.2016.12.002. Epub 2016 Dec 8.
8
Strategies for target identification of antimicrobial natural products.抗菌天然产物的靶标鉴定策略。
Nat Prod Rep. 2016 May 4;33(5):668-80. doi: 10.1039/c5np00127g.
9
Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies.用于抗生素发现的莽草酸激酶和II型脱氢奎尼酸酶的抑制作用:基于结构的设计与模拟研究。
Curr Top Med Chem. 2016;16(9):960-77. doi: 10.2174/1568026615666150825142527.
10
Novel antibacterials: a genomics approach to drug discovery.新型抗菌药物:药物发现的基因组学方法
Curr Drug Targets Infect Disord. 2002 Dec;2(4):291-308. doi: 10.2174/1568005023342227.

本文引用的文献

1
Bacterial Biofilm Eradication Agents: A Current Review.细菌生物膜根除剂:当前综述
Front Chem. 2019 Nov 28;7:824. doi: 10.3389/fchem.2019.00824. eCollection 2019.
2
A new antibiotic selectively kills Gram-negative pathogens.一种新型抗生素能有选择性地杀死革兰氏阴性病原体。
Nature. 2019 Dec;576(7787):459-464. doi: 10.1038/s41586-019-1791-1. Epub 2019 Nov 20.
3
Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms.作为一个社区的生存之道:细菌生物膜中的抗生素耐药性和持久性。
Cell Host Microbe. 2019 Jul 10;26(1):15-21. doi: 10.1016/j.chom.2019.06.002.
4
Identification of Small Molecules Exhibiting Oxacillin Synergy through a Novel Assay for Inhibition of Expression in Methicillin-Resistant Staphylococcus aureus.通过一种新型的抑制耐甲氧西林金黄色葡萄球菌表达的测定法鉴定具有苯唑西林协同作用的小分子。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.02593-18. Print 2019 Sep.
5
Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase Inhibitors.一类基于磺酰胺的氧硼杂环戊烷亮氨酰-tRNA合成酶抑制剂的抗菌活性及作用方式
ACS Infect Dis. 2019 Jul 12;5(7):1231-1238. doi: 10.1021/acsinfecdis.9b00071. Epub 2019 May 1.
6
Structure-Based Design, Synthesis, and Biological Evaluation of Non-Acyl Sulfamate Inhibitors of the Adenylate-Forming Enzyme MenE.基于结构的腺苷酸形成酶 MenE 的非酰基磺胺抑制剂的设计、合成与生物评价。
Biochemistry. 2019 Apr 9;58(14):1918-1930. doi: 10.1021/acs.biochem.9b00003. Epub 2019 Mar 26.
7
The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus.喹唑啉酮类 PBP2a 变构抑制剂与哌拉西林-他唑巴坦联合使用对耐甲氧西林金黄色葡萄球菌具有协同作用。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02637-18. Print 2019 May.
8
Ultra-large library docking for discovering new chemotypes.超大库对接发现新化学型。
Nature. 2019 Feb;566(7743):224-229. doi: 10.1038/s41586-019-0917-9. Epub 2019 Feb 6.
9
Discovery of a cofactor-independent inhibitor of InhA.InhA的一种不依赖辅因子的抑制剂的发现。
Life Sci Alliance. 2018 Jun 1;1(3):e201800025. doi: 10.26508/lsa.201800025. eCollection 2018 Jun.
10
Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance.合成小分子作为对抗抗生素耐药性的抗生物膜剂。
Eur J Med Chem. 2019 Jan 1;161:154-178. doi: 10.1016/j.ejmech.2018.10.036. Epub 2018 Oct 17.